A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR
A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra®) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR).
Sponsor: Mundipharma Research Limited
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Mundipharma Research Limited
- Invasive Fungal Infections · Phase PHASE1 · Oct 2024
- Indolent B-cell NHL · Phase PHASE3 · Jul 2018
- ACOS (Fixed Airflow Obstruction and Elevated Eosinophils) · Phase PHASE2/PHASE3 · Dec 2016
- Chemotherapy Induced Mucositis · Phase PHASE1/PHASE2 · Nov 2012
- Severe Caner Pain · Phase PHASE3 · Jun 2009
More terminations from Mundipharma Research Limited
Other Polymyalgia Rheumatica trials with similar outcome
A PHASE3 clinical study on Polymyalgia Rheumatica, this trial is terminated or withdrawn. The trial is conducted by Mundipharma Research Limited and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Nov 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mundipharma Research Limited
For direct contact, visit the study record on ClinicalTrials.gov .